Changes in Latitude, Changes in Attitude

After a few cold weeks in the Northeast, we’re thinking about warmer places.


Following Brinker’s earnings release this morning, we decided to make two changes to our Investment Ideas list.

  1. Remove BLMN from the Long List
  2. Bump up DFRG to the Short List


Changes in Latitude, Changes in Attitude - 1


Inflation is the common theme for both of these names.  Red meat inflation, in particular, is the one commodity we believe will limit upside to earnings – despite strong sales trends.  On the EAT call, management cited “unfavorable commodity pricing stemming from a greater than anticipated increase in the price of burger meat, cheese and avocados,” as a significant headwind to EPS during the quarter.  We suspect that won't change anytime soon.  Next quarter, EAT will be rolling a difficult comp, when cost of sales were down 93 bps y/y in 3Q14.


BLMN: All Good Things Must Come to an End

BLMN has enjoyed a nice run since the end September of last year, when we added it to our Long List.  The stock is up 6% and 31% over the past one and three months, respectively.  Unfortunately, we believe the stock has a lot of good news baked into it ahead of the quarter.  Given the recent stock move and earnings estimates that have remained flat, the stock is finally trading in-line with the group.  If we thought there was significant upside to earnings, we’d stay long the name – but we don’t believe that to be the case.  There has never been a significant amount of leverage in the BLMN business model, which has traditionally relied on pricing and productivity, to offset commodity inflation, to protect margins.  In addition to the aforementioned, the overwhelmingly positive sentiment gives us incremental cause for concern.


Recent Notes

11/04/14 BLMN: Notable Progress, Still Bullish

10/02/14 BLMN: Bullish on Bloomin’

09/25/14 BLMN: Same As It Ever Was


Changes in Latitude, Changes in Attitude - 2

Source: FactSet


DFRG: Hello Darkness, My Old Friend

The bottom line on DFRG is a little more sinister, because the business model is broken.  In our view, DFRG should not open another Del Frisco’s Grille for the foreseeable future – never mind six this year!  Please refer to the Black Book we published back in July 2014 for additional details.  Perhaps more importantly, however, is the fact that the company will not grow EPS 17% in 2015 and it certainly won’t accelerate to 23% in FY16. 


Trading at 20x an inflated NTM EPS estimate, the stock looks like a good value.  Alas, consensus reflects a recovery that will not happen.  The optimism in DFRG’s earnings estimates is a direct reflection of the 100% buy rating on the stock.  The target price of $27.60 suggests 37% upside from current levels.  If we set price targets here at Hedgeye (we don't), ours would be closer to $10 (~50% downside).


Recent Notes

10/16/14 DFRG: Timing is Critical

10/09/14 DFRG, EAT: Covering Our Shorts Given Strong Knapp Sales

07/22/14 DFRG: Inflated Multiple Deflating

07/21/14 DFRG: Thoughts into the Print

07/02/14 DFRG: A Castle-in-the-Air

06/16/14 DFRG: Running Through Our Thesis

06/05/14 New Best Idea: Short DFRG


Changes in Latitude, Changes in Attitude - 3

Source: FactSet

7 Tweets Summing Up What You Need to Know About Today's GDP Report

"There's a tremendous opportunity to educate people in our profession on how GDP is stated and projected," Hedgeye CEO Keith McCullough wrote today. Here's everything you need to know about today's GDP report.

read more

Cartoon of the Day: Crash Test Bear

In the past six months, U.S. stock indices are up between +12% and +18%.

read more

GOLD: A Deep Dive on What’s Next with a Top Commodities Strategist

“If you saved in gold over the past 20 to 25 years rather than any currency anywhere in the world, gold has outperformed all these currencies,” says Stefan Wieler, Vice President of Goldmoney in this edition of Real Conversations.

read more

Exact Sciences Up +24% This Week... What's Next? | $EXAS

We remain long Exact Sciences in the Hedgeye Healthcare Position Monitor.

read more

Inside the Atlanta Fed's Flawed GDP Tracker

"The Atlanta Fed’s GDPNowcast model, while useful at amalgamating investor consensus on one singular GDP estimate for any given quarter, is certainly not the end-all-be-all of forecasting U.S. GDP," writes Hedgeye Senior Macro analyst Darius Dale.

read more

Cartoon of the Day: Acrophobia

"Most people who are making a ton of money right now are focused on growth companies seeing accelerations," Hedgeye CEO Keith McCullough wrote in today's Early Look. "That’s what happens in Quad 1."

read more

People's Bank of China Spins China’s Bad-Loan Data

PBoC Deputy Governor Yi says China's non-performing loan problem has “pretty much stabilized." "Yi is spinning. China’s bad-debt problem remains serious," write Benn Steil and Emma Smith, Council on Foreign Relations.

read more

UnderArmour: 'I Am Much More Bearish Than I Was 3 Hours Ago'

“The consumer has a short memory.” Yes, Plank actually said this," writes Hedgeye Retail analyst Brian McGough. "Last time I heard such arrogance was Ron Johnson."

read more

Buffalo Wild Wings: Complacency & Lack of Leadership (by Howard Penney)

"Buffalo Wild Wings has been plagued by complacency and a continued lack of adequate leadership," writes Hedgeye Restaurants analyst Howard Penney.

read more

Todd Jordan on Las Vegas Sands Earnings

"The quarter actually beat lowered expectations. Overall, the mass segment performed well although base mass lagging is a concern," writes Hedgeye Gaming, Lodging & Leisure analyst Todd Jordan on Las Vegas Sands.

read more

An Update on Defense Spending by Lt. Gen Emo Gardner

"Congress' FY17 omnibus appropriation will fully fund the Pentagon's original budget request plus $15B of its $30B supplemental request," writes Hedgeye Potomac Defense Policy analyst Lt. Gen Emerson "Emo" Gardner USMC Ret.

read more

Got Process? Zero Hedge Sells Fear, Not Truth

Fear sells. Always has. Look no further than Zero Hedge.

read more